Nonimmune binding of human immunoglobulins G and A by Streptococcus pyogenes: the role of this phenomenon in pathology

Abstract

M and M-like proteins are key pathogenicity factors of Streptococcus pyogenes, a widely prevalent and potentially lethal bacterium. These proteins confer resistance to the host’s innate and adaptive immune response by attracting specific human proteins to the streptococcal surface. The nonimmune binding of host immunoglobulins G (IgG) and A (IgA) to M and M-like proteins via their Fc domains was first described over 50 years ago, but its role in the pathogenicity of S. pyogenes remains unclear. This discovery has had a significant impact on the development of innovative diagnostic approaches, technologies, and tools in microbiology, immunology, and molecular biology. The nonimmune binding of immunoglobulins has been suggested to play a role in immune conditions on mucosal surfaces and their secretions, but not in blood plasma, while other studies suggest it protects microbes from phagocytosis in the host’s nonimmune blood. The Fc-binding effect has been shown to increase the pathogenicity of streptococci, contributing to the development of autoimmune diseases and tissue damage in experimental animals. The experimental autoimmune process can be prevented by administering purified Fc fragments of immunoglobulins to animals. Streptococcal diseases play a significant role in the pathogenesis of IgA-nephropathy (IgAN), a mesangial proliferative process caused by initial IgA-Fcα deposition in renal mesangium cells. Literature suggests a relevance of recent ideas about the important role of nonimmune Ig binding in streptococcal diseases, and further efforts are required to study the binding of Fc fragments of IgG and IgA to M and M-like proteins of S. pyogenes, with the aim of developing preventive and potentially therapeutic applications. The paper speculates on the role of nonimmune Ig binding in streptococcal diseases, including cases with various mechanisms of development. These studies also focuses on preventive and potentially therapeutic applications of Fc fragments of IgG to M or M-like proteins of S. pyogenes.

Keywords

Streptococcus pyogenes / streptococcal IgFc-binding proteins / post-streptococcal glomerulonephritis / myocarditis / IgA-nephropathy

References

[1] Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. DOI: 10.1038/nrdp.2015.84

[2] Carapetis J.R., Beaton A., Cunningham M.W. et al. Acute rheumatic fever and rheumatic heart disease // Nat. Rev. Dis. Primers. 2016. No. 2. ID 15084. DOI: 10.1038/nrdp.2015.84

[3] Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–694. DOI: 10.1016/S1473-3099(05)70267-X

[4] Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases // Lancet. Infect. Dis. 2005. Vol. 5, No. 11. P. 685–694. DOI: 10.1016/S1473-3099(05)70267-X

[5] Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377(8):713–722. DOI: 10.1056/NEJMoa1603693

[6] Watkins D.A., Johnson C.O., Colquhoun S.M. et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015 // N. Engl. J. Med. 2017. Vol. 377, No. 8. P. 713–722. DOI: 10.1056/NEJMoa1603693

[7] Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470–511. DOI: 10.1128/cmr.13.3.470

[8] Cunningham M.W. Pathogenesis of group A streptococcal infections // Clin. Microbiol. Rev. 2000. Vol. 13, No. 3. P. 470–511. DOI:10.1128/cmr.13.3.470

[9] Ghosh P. Variation, indispensability, and masking in the M protein. Trends Microbiol. 2018;26(2):132–144. DOI: 10.1016/j.tim.2017.08.002

[10] Ghosh P. Variation, indispensability, and masking in the M protein // Trends Microbiol. 2018. Vol. 26, No. 2. P. 132–144. DOI: 10.1016/j.tim.2017.08.002

[11] Phillips GNJr, Flicker PF, Cohen C, et al. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci USA. 2018;78(8):4689–4693. DOI: 10.1073/pnas.78.8.4689

[12] Phillips G.N. Jr., Flicker P.F., Cohen C. et al. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface // Proc. Natl. Acad. Sci. USA. 2018. Vol. 78, No. 8. P. 4689–4693. DOI:10.1073/pnas.78.8.4689

[13] McMillan DJ, Dreze PA, Vu T, et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect. 2013;19(5):E222–229. DOI: 10.1111/1469-0691.12134

[14] McMillan D.J., Dreze P.A., Vu T. et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study // Clin. Microbiol. Infect. 2013. Vol. 19, No. 5. P. E222–229. DOI: 10.1111/1469-0691.12134

[15] Mills JO, Ghosh P. Nonimmune antibody interactions of Group A Streptococcus M and M-like proteins. PLoS Pathog. 2021;17(2):e1009248. DOI: 10.1371/journal.ppat.1009248

[16] Mills J.O., Ghosh P. Nonimmune antibody interactions of group A Streptococcus M and M-like proteins // PLoS Pathog. 2021. Vol. 17, No. 2. P. e1009248. DOI: 10.1371/journal.ppat.1009248

[17] Haanes EJ, Heath DG, Cleary PP. Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol. 1992;174(15):4967–4976. DOI: 10.1128/jb.174.15.4967-4976.1992

[18] Haanes E.J., Heath D.G., Cleary P.P. Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class // J. Bacteriol. 1992. Vol. 174, No. 15. P. 4967–4976. DOI: 10.1128/jb.174.15.4967-4976.1992

[19] Hollingshead SK, Readdy TL, Yung DL, Bessen DE. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol Microbiol. 1993;8(4):707–717. DOI: 10.1111/j.1365-2958.1993.tb01614.x

[20] Hollingshead S.K., Readdy T.L., Yung D.L., Bessen D.E. Structural heterogeneity of the emm gene cluster in group A streptococci // Mol. Microbiol. 1993. Vol. 8, No. 4. P. 707–717. DOI: 10.1111/j.1365-2958.1993.tb01614.x

[21] Flores AR, Olsen RJ, Wunsche A, et al. Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interaction in group A Streptococcus carrier strains. Infect Immun. 2013;81(11):4128–4138. DOI: 10.1128/IAI.00405-13

[22] Flores A.R., Olsen R.J., Wunsche A. et al. Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interaction in group A Streptococcus carrier strains // Infect. Immun. 2013. Vol. 81, No. 11. P. 4128–4138. DOI: 10.1128/IAI.00405-13

[23] Facklam R, Beall B, Efstratiou A, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis. 1999;5(2):247–253. DOI: 10.3201/eid0502.990209

[24] Facklam R., Beall B., Efstratiou A. et al. emm typing and validation of provisional M types for group A streptococci // Emerg. Infect. Dis. 1999. Vol. 5, No. 2. P. 247–253. DOI: 10.3201/eid0502.990209

[25] Ringdahl U, Svensson HG, Kotarsky H, et al. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol. 2000;37(6):1318–1326. DOI: 10.1046/j.1365-2958.2000.02062.x

[26] Ringdahl U., Svensson H.G., Kotarsky H. et al. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance // Mol. Microbiol. 2000. Vol. 37, No. 6. P. 1318–1326. DOI: 10.1046/j.1365-2958.2000.02062.x

[27] Carlsson F, Sandin C, Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol. 2005;56(1):28–39. DOI: 10.1111/j.1365-2958.2005.04527.x

[28] Carlsson F., Sandin C., Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway // Mol. Microbiol. 2005. Vol. 56, No. 1. P. 28–39. DOI: 10.1111/j.1365-2958.2005.04527.x

[29] Macheboeuf P, Buffalo C, Fu CY, et al. Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature. 2011;472(7341):64–68. DOI: 10.1038/nature09967

[30] Macheboeuf P., Buffalo C., Fu C.Y. et al. Streptococcal M1 protein constructs a pathological host fibrinogen network // Nature. 2011. Vol. 472, No. 7341. P. 64–68. DOI: 10.1038/nature09967

[31] Thern A, Stenberg L, Dahlback B, Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol. 1995;154(1):375–386.

[32] Thern A., Stenberg L., Dahlback B., Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system // J. Immunol. 1995. Vol. 154, No. 1. P. 375–386.

[33] Berggard K, Johnsson E, Morfeldt E, et al. Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol. 2001;42(2):539–551. DOI: 10.1046/j.1365-2958.2001.02664.x

[34] Berggard K., Johnsson E., Morfeldt E. et al. Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes // Mol. Microbiol. 2001. Vol. 42, No. 2. P. 539–551. DOI: 10.1046/j.1365-2958.2001.02664.x

[35] Buffalo CZ, Bahn-Suh AJ, Hirakis SP, et al. Conserved patterns hidden within group A Streptococcus M protein hypervariability recognize human C4b-binding protein. Nat Microbiol. 2016;1:16155. DOI: 10.1038/nmicrobiol.2016.155

[36] Buffalo C.Z., Bahn-Suh A.J., Hirakis S.P. et al. Conserved patterns hidden within group A Streptococcus M protein hypervariability recognize human C4b-binding protein // Nat. Microbiol. 2016. No. 1. P. 16155. DOI: 10.1038/nmicrobiol.2016.155

[37] Sandin C, Carlsson F, Lindahl G. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol. 2006;59(1):20–30. DOI: 10.1111/j.1365-2958.2005.04913.x

[38] Sandin C., Carlsson F., Lindahl G. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes // Mol. Microbiol. 2006. Vol. 59, No. 1. P. 20–30. DOI: 10.1111/j.1365-2958.2005.04913.x

[39] Akesson P, Schmidt KH, Cooney J, Björck L. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J. 1994;300(Pt 3):877–886. DOI: 10.1042/bj3000877

[40] Akesson P., Schmidt K.H., Cooney J., Björck L. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes // Biochem. J. 1994. Vol. 300, No. Pt 3. P. 877–886. DOI: 10.1042/bj3000877

[41] Nilson BH, Frick IM, Akesson P, et al. Structure and stability of protein H and the M1 protein from Streptococcus pyogenes. Implications for other surface proteins of grampositive bacteria. Biochemistry. 1995;34(41):13688–13698. DOI: 10.1021/bi00041a051

[42] Nilson B.H., Frick I.M., Akesson P. et al. Structure and stability of protein H and the M1 protein from Streptococcus pyogenes. Implications for other surface proteins of grampositive bacteria // Biochemistry. 1995. Vol. 34, No. 41. P. 13688–13698. DOI: 10.1021/bi00041a051

[43] Ermert D, Weckel A, Agarwal V, et al. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells. J Biol Chem. 2013;288(45):32172–32183. DOI: 10.1074/jbc.M113.502955

[44] Ermert D., Weckel A., Agarwal V. et al. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells // J. Biol. Chem. 2013. Vol. 288, No. 45. P. 32172–32183. DOI: 10.1074/jbc.M113.502955

[45] Berge A, Sjobring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem. 1993;268(34):25417–25424.

[46] Berge A., Sjobring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes // J. Biol. Chem. 1993. Vol. 268, No. 34. P. 25417–25424.

[47] Wistedt AC, Ringdahl U, Muller-Esterl W, Sjobring U. Identification of a plasminogen-binding motif in PAM, a bacterial surface protein. Mol Microbiol. 1995;18(3):569–578. DOI: 10.1111/j.1365-2958.1995.mmi_18030569.x

[48] Wistedt A.C., Ringdahl U., Muller-Esterl W., Sjobring U. Identification of a plasminogen-binding motif in PAM, a bacterial surface protein // Mol. Microbiol. 1995. Vol. 18, No. 3. P. 569–578. DOI: 10.1111/j.1365-2958.1995.mmi_18030569.x

[49] Rios-Steiner JL, Schenone M, Mochalkin I, et al. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group a Streptococcal surface protein. Mol Biol. 2001;308(4):705–719. DOI: 10.1006/jmbi.2001.4646

[50] Rios-Steiner J.L., Schenone M., Mochalkin I. et al. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group a Streptococcal surface protein // Mol. Biol. 2001. Vol. 308, No. 4. P. 705–719. DOI: 10.1006/jmbi.2001.4646

[51] Sun H, Ringdahl U, Homeister JW, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science. 2004;305(5688):1283–1286. DOI: 10.1126/science.1101245

[52] Sun H., Ringdahl U., Homeister J.W. et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection // Science. 2004. Vol. 305, No. 5688. P. 1283–1286. DOI: 10.1126/science.1101245

[53] Ly D, Taylor JM, Tsatsaronis JA, et al. Plasmin(ogen) acquisition by group A Streptococcus protects against C3b-mediated neutrophil killing. J Innate Immun. 2014;6(2):240–250. DOI: 10.1159/000353754

[54] Ly D., Taylor J.M., Tsatsaronis J.A. et al. Plasmin(ogen) acquisition by group A Streptococcus protects against C3b-mediated neutrophil killing // J. Innate Immun. 2014. Vol. 6, No. 2. P. 240–250. DOI: 10.1159/000353754

[55] Cole JN, McArthur JD, McKay FC, et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 2006;20(10):1745–1747. DOI: 10.1096/fj.06-5804fje

[56] Cole J.N., McArthur J.D., McKay F.C. et al. Trigger for group A streptococcal M1T1 invasive disease // FASEB J. 2006. Vol. 20, No. 10. P. 1745–1747. DOI: 10.1096/fj.06-5804fje

[57] Kronvall G. A surface component in group A, C and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol. 1973;111(5):1401–1406.

[58] Kronvall G. A surface component in group A, C and G streptococci with non-immune reactivity for immunoglobulin G // J. Immunol. 1973. Vol. 111, No. 5. P. 1401–1406.

[59] Lindahl G, Akerstrom B. Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli. Mol Microbiol. 1989;3(2):239–247. DOI: 10.1111/j.1365-2958.1989.tb01813.x

[60] Lindahl G., Akerstrom B. Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli // Mol. Microbiol. 1989. Vol. 3, No. 2. P. 239–247. DOI: 10.1111/j.1365-2958.1989.tb01813.x

[61] Lindahl G, Stenberg L. Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci. Epidemiol Infect. 1990;105(1):87–93. DOI: 10.1017/s0950268800047683

[62] Lindahl G., Stenberg L. Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci // Epidemiol. Infect. 1990. Vol. 105, No. 1. P. 87–93. DOI: 10.1017/s0950268800047683

[63] Johnsson E, Andersson G, Lindahl G, Heden LO. Identification of the IgA-binding region in streptococcal protein Arp. J Immunol. 1994;153(8):3557–3564.

[64] Johnsson E., Andersson G., Lindahl G., Heden L.O. Identification of the IgA-binding region in streptococcal protein Arp // J. Immunol. 1994. Vol. 153, No. 8. P. 3557–3564.

[65] Bessen DE. Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci. Infect Immun. 1994;62(5):1968–1974. DOI: 10.1128/iai.62.5.1968-1974.1994

[66] Bessen D.E. Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci // Infect. Immun. 1994. Vol. 62, No. 5. P. 1968–1974. DOI: 10.1128/iai.62.5.1968-1974.1994

[67] Lindahl G. An Odyssey in word of M proteins. In: Perspectives on receptins and resistance. Ed. by G. Kronvall. Stockholm; 2013. P. 13–23.

[68] Lindahl G. An Odyssey in word of M proteins. In: Perspectives on receptins and resistance. Ed. by G. Kronvall. Stockholm, 2013. P. 13–23.

[69] Horton RE, Vidarsson G. Antibodies and their receptors: different potential roles in mucosal defense. Front Immunol. 2013;4:200. DOI: 10.3389/fimmu.2013.00200

[70] Horton R.E., Vidarsson G. Antibodies and their receptors: different potential roles in mucosal defense // Front. Immunol. 2013. Vol. 4. P. 200. DOI: 10.3389/fimmu.2013.00200

[71] Cedervall T, Akesson P, Stenberg L, et al. Allosteric and temperature effects on the plasma protein binding by streptococcal M protein family members. Scand J Immunol. 1995;42(4):433–441. DOI: 10.1111/j.1365-3083.1995.tb03677.x

[72] Cedervall T., Akesson P., Stenberg L. et al. Allosteric and temperature effects on the plasma protein binding by streptococcal M protein family members // Scand. J. Immunol. 1995. Vol. 42, No. 4. P. 433–441. DOI: 10.1111/j.1365-3083.1995.tb03677.x

[73] Grov A, Myklestd B, Oeding F. Immunochemical studies on antigen preparations from Staphylococcus aureus. I. Isolation and chemical characterization of antigen A. Acta Pathol Microbiol Scand. 1964;61:588–596. DOI: 10.1111/apm.1964.61.4.588

[74] Grov A., Myklestd B., Oeding F. Immunochemical studies on antigen preparations from Staphylococcus aureus. I. Isolation and chemical characterization of antigen A // Acta Pathol. Microbiol. Scand. 1964. Vol. 61. P. 588–596. DOI: 10.1111/apm.1964.61.4.588

[75] Forsgren A, Sjoquist J. “Protein A” from S. aureus. I. Pseudoimmune reaction with human gamma-globulin. J Immunol. 1966;97(6):822–827.

[76] Forsgren A., Sjoquist J. “Protein A” from S. aureus. I. Pseudoimmune reaction with human gamma-globulin // J. Immunol. 1966. Vol. 97, No. 6. P. 822–827.

[77] Myhre EB, Kronvall G. Immunoglobulin binding to group A, C and G streptococci. In: Pathogenic streptococci. Ed. by M.T. Parker. Reedbooks Ltd, England; 1979. P. 76–78.

[78] Myhre E.B., Kronvall G. Immunoglobulin binding to group A, C and G streptococci. In: Pathogenic streptococci. Ed. by M.T. Parker. Reedbooks Ltd, England, 1979. P. 76–78.

[79] Myhre EB, Kronvall G. Heterogeneity of nonimmune immunoglobulin Fc reactivity among gram-positive cocci. Description of three major types of receptors for human immunoglobulin G. Infect Immun. 1977;17(3):475–482. DOI: 10.1128/IAI.17.3.475-482.1977

[80] Myhre E.B., Kronvall G. Heterogeneity of nonimmune immunoglobulin Fc reactivity among gram-positive cocci. Description of three major types of receptors for human immunoglobulin G // Infect. Immun. 1977. Vol. 17, No. 3. P. 475–482. DOI: 10.1128/IAI.17.3.475-482.1977

[81] Christensen P, Sramec J, Zatterstrom U. Binding of aggregated IgG in the presence of fresh serum: strong association with type 12 group A streptococci. Acta Pathol Microbiol Scand B. 1981;89(2):87–91. DOI: 10.1111/j.1699-0463.1981.tb00158_89b.x

[82] Christensen P., Sramec J., Zatterstrom U. Binding of aggregated IgG in the presence of fresh serum: strong association with type 12 group A streptococci // Acta Pathol. Microbiol. Scand. B. 1981. Vol. 89, No. 2. P. 87–91. DOI: 10.1111/j.1699-0463.1981.tb00158_89b.x

[83] Schalen C, Kurl DN, Christensen P. Independent binding of native and aggregated IgG in group A streptococci. APMIS. 1986;94(5):333–338. DOI: 10.1111/j.1699-0463.1986.tb03062.x

[84] Schalen C., Kurl D.N., Christensen P. Independent binding of native and aggregated IgG in group A streptococci // APMIS. 1986. Vol. 94, No. 5. P. 333–338. DOI: 10.1111/j.1699-0463.1986.tb03062.x

[85] Burova L, Pigarevsky P, Duplik N, et al. Immune complex binding Streptococcus pyogenes type M12/emm12 in experimental glomerulonephritis. J Med Microbiol. 2013;62(Pt 9):1272–1280. DOI: 10.1099/jmm.0.059196-0

[86] Burova L., Pigarevsky P., Duplik N. et al. Immune complex binding Streptococcus pyogenes type M12/emm12 in experimental glomerulonephritis // J. Med. Microbiol. 2013. Vol. 62(Pt 9). P. 1272–1280. DOI: 10.1099/jmm.0.059196-0

[87] Burova L, Therne A, Pigarevsky P, et al. Role of group A streptococcal IgG-binding proteins in triggering experimental glomerulonephritis in the rabbit. APMIS. 2003;111(10):955–962. DOI: 10.1034/j.1600-0463.2003.1111007.x

[88] Burova L., Therne A., Pigarevsky P. et al. Role of group A streptococcal IgG-binding proteins in triggering experimental glomerulonephritis in the rabbit // APMIS. 2003. Vol. 111, No. 10. P. 955–962. DOI: 10.1034/j.1600-0463.2003.1111007.x

[89] Burova LA, Nagornev VA, Pigarevsky PV, et al. Myocardial tissue damage in rabbits injected with group A streptococci, types M1 and M22. Role of bacterial immunoglobulin G-binding surface proteins. APMIS. 2005;113(1):21–30. DOI: 10.1111/j.1600-0463.2005.apm1130104.x

[90] Burova L.A., Nagornev V.A., Pigarevsky P.V. et al. Myocardial tissue damage in rabbits injected with group A streptococci, types M1 and M22. Role of bacterial immunoglobulin G-binding surface proteins // APMIS. 2005. Vol. 113, No. 1. P. 21–30. DOI: 10.1111/j.1600-0463.2005.apm1130104.x

[91] Heath DG, Cleary PP. Fc-receptor and M protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci USA. 1989;86(12):4741–4745. DOI: 10.1073/pnas.86.12.4741

[92] Heath D.G., Cleary P.P. Fc-receptor and M protein genes of group A streptococci are products of gene duplication // Proc. Natl. Acad. Sci. USA. 1989. Vol. 86, No. 12. P. 4741–4745. DOI: 10.1073/pnas.86.12.4741

[93] Stenberg L, O’Toole P, Lindahl G. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol Microbiol. 1992;6(9):1185–1194. DOI: 10.1111/j.1365-2958.1992.tb01557.x

[94] Stenberg L., O’Toole P., Lindahl G. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type // Mol. Microbiol. 1992. Vol. 6, No. 9. P. 1185–1194. DOI: 10.1111/j.1365-2958.1992.tb01557.x

[95] Hollingshead SK, Arnold J, Readdy TL, Bessen DE. Molecular evolution of a multigene family in group A Streptococci. Mol Biol Evol. 1994;11(2):208–219. DOI: 10.1093/oxfordjournals.molbev.a040103

[96] Hollingshead S.K., Arnold J., Readdy T.L., Bessen D.E. Molecular evolution of a multigene family in group A Streptococci // Mol. Biol. Evol. 1994. Vol. 11, No. 2. P. 208–219. DOI: 10.1093/oxfordjournals.molbev.a040103

[97] Schroder AK, Nardella FA, Mannik M, et al. Identification of the site on IgG Fc for interaction with streptococci of groups A, C and G. Immunology. 1987;62(4):523–527.

[98] Schroder A.K., Nardella F.A., Mannik M. et al. Identification of the site on IgG Fc for interaction with streptococci of groups A, C end G // Immunology. 1987. Vol. 62, No. 4. P. 523–527.

[99] Christensen P, Oxelius V-A. A reaction between some streptococci and IgA myeloma proteins. Acta Pathol Microbiol Scand C Immunol. 1975;83C(3):184–188. DOI: 10.1111/j.1699-0463.1975.tb01624.x

[100] Christensen P., Oxelius V.-A. A reaction between some streptococci and IgA myeloma proteins // Acta Pathol. Microbiol. Scand. C Immunol. 1975. Vol. 83C, No. 3. P. 184–188. DOI: 10.1111/j.1699-0463.1975.tb01624.x

[101] Kronvall G, Björck L, Myhre EB, Wannamaker LW. Binding of aggregated β2-microglobulin, IgG, IgA and fibrinogen to group A, C and G streptococci with special reference to streptococcal M protein. In: Pathogenic streptococci. Ed. by M.T. Parker. Reedbooks Ltd, England; 1979. P. 74–76.

[102] Kronvall G., Björck L., Myhre E.B., Wannamaker L.W. Binding of aggregated β2-microglobulin, IgG, IgA and fibrinogen to group A, C and G streptococci with special reference to streptococcal M protein. // Pathogenic streptococci. Ed. by M.T. Parker. Reedbooks Ltd, England, 1979. P. 74–76.

[103] Lebrun L, Pillot J, Grangeot-Keros L. Significance of anti-IgG antibodies obtained by immunization of rabbits with same streptococcal strains. Ann Immunol (Paris). 1982;133C(1):45–56. DOI: 10.1016/0769-2625(82)90005-8

[104] Lebrun L., Pillot J., Grangeot-Keros L. Significance of anti-IgG antibodies obtained by immunization of rabbits with same streptococcal strains // Ann. Immunol. (Paris). 1982. Vol. 133C, No. 1. P. 45–56. DOI: 10.1016/0769-2625(82)90005-8

[105] Grubb R, Burova L, Hultguist R, et al. Anti-IgG-allotypic specifities of spontaneously occurring anti-immunoglobulins. In: Antibodies-protective, destructive and regulatory role. F. Milgrome, C. Abeyounis, B. Albini (Eds.). Karger, Basel; 1985. P. 224–233.

[106] Grubb R., Burova L., Hultguist R. et al. Anti-IgG-allotypic specifities of spontaneously occurring anti-immunoglobulins In: Antibodies-protective, destructive and regulatory role. F. Milgrome, C. Abeyounis, B. Albini (Eds.). Karger, Basel, 1985. P. 224–233.

[107] Burova LA, Christensen P, Grubb R, et al. Anti-immunoglobulins in experimental streptococcal immunization: relation to bacterial growth conditions and Fc-receptors. Acta Pathol Microbiol Immunol Scand C. 1985;93(1):19–23. DOI: 10.1111/j.1699-0463.1985.tb02916.x

[108] Burova L.A., Christensen P., Grubb R. et al. Anti-immunoglobulins in experimental streptococcal immunization: relation to bacterial growth conditions and Fc-receptors // Acta Pathol. Microbiol. Immunol. Scand. C. 1985. Vol. 93, No. 1. P. 19–23. DOI: 10.1111/j.1699-0463.1985.tb02916.x

[109] Barabas AZ, Cole CD, Lafreniere R, Weir DM. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease. Autoimmunity. 2012;45(7):495–509. DOI: 10.3109/08916934.2012.702812

[110] Barabas A.Z., Cole C.D., Lafreniere R., Weir D.M. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease // Autoimmunity. 2012. Vol. 45, No. 7. P. 495–509. DOI: 10.3109/08916934.2012.702812

[111] Rodriguez-Iturbe B. Autoimmunity in acute poststreptococcal GN: A neglected aspect of the disease. JASN. 2021;32(3):534–542. DOI: 10.1681/ASN.2020081228

[112] Rodriguez-Iturbe B. Autoimmunity in acute poststreptococcal GN: a neglected aspect of the disease // JASN. 2021. Vol. 32, No. 3. P. 534–542. DOI: 10.1681/ASN.2020081228

[113] Rodriguez-Iturbe B, Haas M. Post-Streptococcal Glomerulonephritis. In: Streptococcus pyogenes: Basic Biology to Clinical Manifestations. J.J. Ferretti, D.L. Stevens, V.A. Fischetti (Eds.) [Internet]. Oklahoma City: University of Oklahoma, Health Sciences Center; 2016.

[114] Rodriguez-Iturbe B., Haas M. Post-Streptococcal Glomerulonephritis // Streptococcus pyogenes: Basic Biology to Clinical Manifestations. J.J. Ferretti, D.L. Stevens, V.A. Fischetti (Eds.) [Internet]. Oklahoma City: University of Oklahoma, Health Sciences Center, 2016.

[115] Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet. 1983;1(8331):945–948. DOI: 10.1016/s0140-6736(83)92078-0

[116] Barnham M., Thornton T.J., Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C) // Lancet. 1983. Vol. 1, No. 8331. P. 945–948. DOI: 10.1016/s0140-6736(83)92078-0

[117] Balter S, Benin A, Pinto SW, et al. Epidemic nephritis in Nova Serrana, Brazil. Lancet. 2000;355(9217):1776–1780. DOI: 10.1016/s0140-6736(00)02265-0

[118] Balter S., Benin A., Pinto S.W. et al. Epidemic nephritis in Nova Serrana, Brazil // Lancet. 2000. Vol. 355, No. 9217. P. 1776–1780. DOI: 10.1016/s0140-6736(00)02265-0

[119] Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med. 1999;107(1A):12S–27S. DOI: 10.1016/s0002-9343(99)00103-5

[120] Taylor S.N., Sanders C.V. Unusual manifestations of invasive pneumococcal infection // Am. J. Med. 1999. Vol. 107, No. 1A. P. 12S–27S. DOI: 10.1016/s0002-9343(99)00103-5

[121] Phillips J, Palmer A, Baliga R. Glomerulonephritis associated with acute pneumococcal pneumonia: a case report. Pediatr Nephrol. 2005;20(10):1494–1495. DOI: 10.1007/s00467-005-1994-6

[122] Phillips J., Palmer A., Baliga R. Glomerulonephritis associated with acute pneumococcal pneumonia: a case report // Pediatr. Nephrol. 2005. Vol. 20, No. 10. P. 1494–1495. DOI: 10.1007/s00467-005-1994-6

[123] Almroth G, Lindell A, Aselius H, et al. Acute glomerulonephritis associated with Streptococcus pyogenes with concomitant spread of Streptococcus constellatus in four rural families. Ups J Med Sci. 2005;110(3):217–231. DOI: 10.3109/2000-1967-067

[124] Almroth G., Lindell A., Aselius H. et al. Acute glomerulonephritis associated with Streptococcus pyogenes with concomitant spread of Streptococcus constellatus in four rural families // Ups. J. Med. Sci. 2005. Vol. 110, No. 3. P. 217–231. DOI: 10.3109/2000-1967-067

[125] Maharaj S, Seegobin K, Chrzanowski S, Chang S. Acute glomerulonephritis secondary to Streptococcus anginosus. BMJ Case Rep. 2018;2018: bcr2017223314. DOI: 10.1136/bcr-2017-223314

[126] Maharaj S., Seegobin K., Chrzanowski S., Chang S. Acute glomerulonephritis secondary to Streptococcus anginosus // BMJ Case Rep. 2018. Vol. 2018. P. bcr2017223314. DOI: 10.1136/bcr-2017-223314

[127] Nordstrand A, Norgren M, Ferretti JJ, Holm SE. Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun. 1998;66(1):315–321. DOI: 10.1128/IAI.66.1.315-321.1998

[128] Nordstrand A., Norgren M., Ferretti J.J., Holm S.E. Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model // Infect. Immun. 1998. Vol. 66, No. 1. P. 315–321. DOI: 10.1128/IAI.66.1.315-321.1998

[129] Nordstrand A, McShan WM, Ferretti JJ, et al. Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131. Infect Immun. 2000;68(3):1019–1025. DOI: 10.1128/iai.68.3.1019-1025.2000

[130] Nordstrand A., McShan W.M., Ferretti J.J. et al. Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131 // Infect. Immun. 2000. Vol. 68, No. 3. P. 1019–1025. DOI: 10.1128/iai.68.3.1019-1025.2000

[131] Yoshizawa N, Yamakami K, Fujino M, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. 2004;15(7):1785–1793. DOI: 10.1097/01.asn.0000130624.94920.6b

[132] Yoshizawa N., Yamakami K., Fujino M. et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response // J. Am. Soc. Nephrol. 2004. Vol. 15, No. 7. P. 1785–1793. DOI: 10.1097/01.asn.0000130624.94920.6b

[133] Luo YH, Kuo CF, Huang KJ, et al. Streptococcal pyrogenic exotoxin B antibodies in a mouse model of glomerulonephritis. Kidney Int. 2007;72(6):716–724. DOI: 10.1038/sj.ki.5002407

[134] Luo Y.H., Kuo C.F., Huang K.J. et al. Streptococcal pyrogenic exotoxin B antibodies in a mouse model of glomerulonephritis // Kidney Int. 2007. Vol. 72, No. 6. P. 716–724. DOI: 10.1038/sj.ki.5002407

[135] Honda-Ogawa M, Ogawa T, Terao Y, et al. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J Biol Chem. 2013;288(22):15854–15864. DOI: 10.1074/jbc.M113.469106

[136] Honda-Ogawa M., Ogawa T., Terao Y. et al. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors // J. Biol. Chem. 2013. Vol. 288, No. 22. P. 15854–15864. DOI: 10.1074/jbc.M113.469106

[137] Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19(10):1855–1864. DOI: 10.1681/ASN.2008010092

[138] Rodriguez-Iturbe B., Musser J.M. The current state of poststreptococcal glomerulonephritis // J. Am. Soc. Nephrol. 2008. Vol. 19, No. 10. P. 1855–1864. DOI: 10.1681/ASN.2008010092

[139] Nordstrand A, Norgren M, Holm SE. An experimental model for acute glomerulonephritis in mice. APMIS. 1996;104(11):805–816. DOI: 10.1111/j.1699-0463.1996.tb04946.x

[140] Nordstrand A., Norgren M., Holm S.E. An experimental model for acute glomerulonephritis in mice // APMIS. 1996. Vol. 104, No. 11. P. 805–816. DOI: 10.1111/j.1699-0463.1996.tb04946.x

[141] Burova LA, Gavrilova EA, Pigarevsky PV, Totolian AA. Role of streptokinase in experimental streptococcal glomerulonephritis. Russian Journal of Infection and Immunity. 2021;11(5):853–864. (In Russ.) DOI: 10.15789/2220-7619-ARO-1594

[142] Бурова Л.А., Гаврилова Е.А., Пигаревский П.В., Тотолян Артем А. Роль стрептокиназы в моделировании постстрептококкового гломерулонефрита // Инфекция и иммунитет. 2021. Т. 11, № 5. С. 853–864. DOI: 10.15789/2220-7619-ARO-1594

[143] Oda T, Yoshizawa N, Yamakami K, et al. Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Hum Pathol. 2010;41(9):1276–1285. DOI: 10.1016/j.humpath.2010.02.006

[144] Oda T., Yoshizawa N., Yamakami K. et al. Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis // Hum. Pathol. 2010. Vol. 41, No. 9. P. 1276–1285. DOI: 10.1016/j.humpath.2010.02.006

[145] McIntosh RM, Allen JE, Rabideua D, et al. The role of interaction between streptococcal products and immunoglobulins in the pathogenesis of glomerular and vascular injure. In: Streptococcal diseases and the immune response. S.E. Read, J.B. Zabriskie (Eds.). New York, London Academic Press; 1980. P. 585–596.

[146] McIntosh R.M., Allen J.E., Rabideua D. et al. The role of interaction between streptococcal products and immunoglobulins in the pathogenesis of glomerular and vascular injure // Streptococcal diseases and the immune response. S.E. Read, J.B. Zabriskie (Eds.). New York, London Academic Press, 1980. P. 585–596.

[147] McIntosh RM, Kaufman DB, McIntosh JR, Griswold W. Glomerular lesions produced in rabbits by autologous serum and autologous IgG modified by treated with a culture of a-hemolytic streptococcus. J Med Microbiol. 1972;5(1):1–7. DOI: 10.1099/00222615-5-1-1

[148] McIntosh R.M., Kaufman D.B., McIntosh J.R., Griswold W.R. Glomerular lesions produced in rabbits by autologous serum and autologous IgG modified by treated with a culture of a-hemolytic streptococcus // J. Med. Microbiol. 1972. Vol. 5, No. 1. P. 1–7. DOI: 10.1099/00222615-5-1-1

[149] Yang R, Otte MA, Hellmark T, et al. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant. 2010;25(8):2479–2486. DOI: 10.1093/ndt/gfq115

[150] Yang R., Otte M.A., Hellmark T. et al. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes // Nephrol. Dial. Transplant. 2010. Vol. 25, No. 8. P. 2479–2486. DOI: 10.1093/ndt/gfq115

[151] Segelmark M, Björck L. Streptococcal enzymes as precision tools against pathogenic IgG autoantibodies in small vessel vasculitis. Front Immunol. 2019;10:2165. DOI: 10.3389/fimmu.2019.02165

[152] Segelmark M., Björck L. Streptococcal enzymes as precision tools against pathogenic IgG autoantibodies in small vessel vasculitis // Front. Immunol. 2019. No. 10. P. 2165. DOI: 10.3389/fimmu.2019.02165

[153] Collin M, Olsén A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun. 2001;69(11):7187–7189. DOI: 10.1128/IAI.69.11.7187-7189.2001

[154] Collin M., Olsén A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins // Infect. Immun. 2001. Vol. 69, No. 11. P. 7187–7189. DOI: 10.1128/IAI.69.11.7187-7189.2001

[155] Collin M, Olsén A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 2001;20(12):3046–3055. DOI: 10.1093/emboj/20.12.3046

[156] Collin M., Olsén A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG // EMBO J. 2001. Vol. 20, No. 12. P. 3046–3055. DOI: 10.1093/emboj/20.12.3046

[157] Burova LA, Schalen C, Koroleva IV, Svensson M-L. Role of group A streptococcal IgG Fc-receptor in induction of anti-IgG by immunization in rabbit. FEMS Microbiol Immunol. 1989;1(8–9):443–448. DOI: 10.1111/j.1574-6968.1989.tb02435.x

[158] Burova L.A., Schalen C., Koroleva I.V., Svensson M.-L. Role of group A streptococcal IgG Fc-receptor in induction of anti-IgG by immunization in rabbit // FEMS Microbiol. Immunol. 1989. Vol. 1, No. 8–9. P. 443–448. DOI: 10.1111/j.1574-6968.1989.tb02435.x

[159] Burova LA, Koroleva IV, Ogurtzov RP, et al. Role of streptococcal IgG Fc-receptor in tissue deposition of IgG in rabbits immunized with Streptococcus pyogenes. APMIS. 1992;100(6):567–574. DOI: 10.1111/j.1699-0463.1992.tb00912.x

[160] Burova L.A., Koroleva I.V., Ogurtzov R.P. et al. Role of streptococcal IgG Fc-receptor in tissue deposition of IgG in rabbits immunized with Streptococcus pyogenes // APMIS. 1992. Vol. 100, No. 6. P. 567–574. DOI: 10.1111/j.1699-0463.1992.tb00912.x

[161] Burova LA, Nagornev VA, Pigarevsky PV, et al. Triggering of renal tissue damage in the rabbit by IgGFc-receptor positive group A streptococci. APMIS. 1998;106(2):277–287. DOI: 10.1111/j.1699-0463.1998.tb01347.x

[162] Burova L.A., Nagornev V.A., Pigarevsky P.V. et al. Triggering of renal tissue damage in the rabbit by IgGFc-receptor positive group A streptococci // APMIS. 1998. Vol. 106, No. 2. P. 277–287. DOI: 10.1111/j.1699-0463.1998.tb01347.x

[163] Burova LA, Pigarevsky PV, Seliverstova VG, et al. Experimental poststreptococcal glomerulonephritis elicited by IgG Fc-binding M family proteins and blocked by IgG Fc-fragment. APMIS. 2012;120(3):221–230. DOI: 10.1111/j.1600-0463.2011.02826.x

[164] Burova L.A., Pigarevsky P.V., Seliverstova V.G. et al. Experimental poststreptococcal glomerulonephritis elicited by IgG Fc-binding M family proteins and blocked by IgG Fc-fragment // APMIS. 2012. Vol. 120, No. 3. P. 221–230. DOI: 10.1111/j.1600-0463.2011.02826.x

[165] Burova LA, Gavrilova EA, Gupalova TV, et al. Inhibition of experimental post-streptococcal glomerulonephritis in rabbits by IgG Fc fragments. In: Streptococci – New Insights into an Old Enemy. Ed. by K.S. Sriprakash. Published by Elsevier, ICS. 2006;1289:359–362. DOI: 10.1016/j.ics.2005.11.005

[166] Burova L.A., Gavrilova E.A., Gupalova T.V. et al. Inhibition of experimental post-streptococcal glomerulonephritis in rabbits by IgG Fc fragments // Streptococci - New Insights into an Old Enemy. Ed. by K.S.Sriprakash. Published by Elsevier, ICS. 2006. Vol. 1289. P. 359–362.

[167] Gomes-Guerrero C, Duque N, Casado MT, et al. Administration of IgGFc-fragments prevents glomerular injury in experimental immune complex nephritis. J Immunol. 2000;164(4):2092–2101. DOI: 10.4049/jimmunol.164.4.2092

[168] Gomes-Guerrero C., Duque N., Casado M.T. et al. Administration of IgGFc-fragments prevents glomerular injury in experimental immune complex nephritis // J. Immunol. 2000. Vol. 164, No. 4. P. 2092–2101. DOI: 10.4049/jimmunol.164.4.2092

[169] Cunningham MW. Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group A Streptococci and their sequelae. Microbiol Spectr. 2019;7(4):10.1128/microbiolspec.GPP3-0045-2018. DOI: 10.1128/microbiolspec.GPP3-0045-2018

[170] Cunningham M.W. Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group A Streptococci and their sequelae // Microbiol. Spectr. 2019. Vol. 7, No. 4. P. 10.1128/microbiolspec.GPP3-0045-2018. DOI: 10.1128/microbiolspec.GPP3-0045-2018

[171] Rafeek RAM, Sikder S, Hamlin AS, et al. Requirements for a robust animal model to investigate the disease mechanism of autoimmune complications associated with ARF/RHD. Front Cardiovasc Med. 2021;8:675339. DOI: 10.3389/fcvm.2021.675339

[172] Rafeek R.A.M., Sikder S., Hamlin A.S. et al. Requirements for a robust animal model to investigate the disease mechanism of autoimmune complications associated with ARF/RHD // Front. Cardiovasc. Med. 2021. Vol. 8. P. 675339. DOI: 10.3389/fcvm.2021.675339

[173] Rafeek RAM, Hamlin AS, Andronicos NM, et al. Characterization of an experimental model to determine streptococcal M protein-induced autoimmune cardiac and neurobehavioral abnormalities. Immunol Cell Biol. 2022;100(8):653–666. DOI: 10.1111/imcb.12571

[174] Rafeek R.A.M., Hamlin A.S., Andronicos N.M. et al. Characterization of an experimental model to determine streptococcal M protein-induced autoimmune cardiac and neurobehavioral abnormalities // Immunol. Cell. Biol. 2022. Vol. 100, No. 8. P. 653–666. DOI: 10.1111/imcb.12571

[175] Burova LA, Nagornev VA, Pigarevsky PV, et al. Induction of myocarditis in rabbits injected with group A streptococci. Indian J Med Res. 2004;119 Suppl:183–185.

[176] Burova L.A., Nagornev V.A., Pigarevsky P.V. et al. Induction of myocarditis in rabbits injected with group A streptococci // Indian. J. Med. Res. 2004. Vol. 119 Suppl. P. 183–185.

[177] Li Y, Heuser JS, Kosanke SD, et al. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol. 2004;172(5):3225–3234. DOI: 10.4049/jimmunol.172.5.3225

[178] Li Y., Heuser J.S., Kosanke S.D. et al. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat // J. Immunol. 2004. Vol. 172, No. 5. P. 3225–3234. DOI: 10.4049/jimmunol.172.5.3225

[179] Gorton D, Sikder S, Williams NL, et al. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Autoimmunity. 2016;49(8):563–570. DOI: 10.1080/08916934.2016.1217999

[180] Gorton D., Sikder S., Williams N.L. et al. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease // Autoimmunity. 2016. Vol. 49, No. 8. P. 563–570. DOI: 10.1080/08916934.2016.1217999

[181] Wyatt RJ, Julian BA. IgA Nephropathy. N Engl J Med. 2013;368(25):2402–2414. DOI: 10.1056/NEJMra1206793

[182] Wyatt R.J., Julian B.A. IgA Nephropathy // N. Engl. J. Med. 2013. Vol. 368, No. 25. P. 2402–2414. DOI: 10.1056/NEJMra1206793

[183] Moriyama T, Tanaka K, Iwasaki C, et al. Prognosis in IgA nephropathy: 30-year analysis of 1012 patients at a single center in Japan. PLoS One. 2014;9(3):e91756. DOI: 10.1371/journal.pone.0091756

[184] Moriyama T., Tanaka K., Iwasaki C. et al. Prognosis in IgA nephropathy: 30-year analysis of 1012 patients at a single center in Japan // PLoS One. 2014. Vol. 9, No. 3. P. e91756. DOI: 10.1371/journal.pone.0091756

[185] Maixnerova D, Reily C, Bian Q, et al. Markers for the progression of IgA nephropathy. J Nephrol. 2016;29(4):535–541. DOI: 10.1007/s40620-016-0299-0

[186] Maixnerova D., Reily C., Bian Q. et al. Markers for the progression of IgA nephropathy // J. Nephrol. 2016. Vol. 29, No. 4. P. 535–541. DOI: 10.1007/s40620-016-0299-0

[187] Suzuki H, Kiryluk K, Novak J, et al. The Pathophysiology of IgA Nephropathy. J Am Soc Nephrol. 2011;22(10):1795–1803. DOI: 10.1681/ASN.2011050464

[188] Suzuki H., Kiryluk K., Novak J. et al. The pathophysiology of IgA nephropathy // J. Am. Soc. Nephrol. 2011. Vol. 22, No. 10. P. 1795–1803. DOI: 10.1681/ASN.2011050464

[189] Boyd JK, Cheung CK, Molyneux K, et al. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012;81(9):833–843. DOI: 10.1038/ki.2011.501

[190] Boyd J.K., Cheung C.K., Molyneux K. et al. An update on the pathogenesis and treatment of IgA nephropathy // Kidney Int. 2012. Vol. 81, No. 9. P. 833–843. DOI: 10.1038/ki.2011.501

[191] Tomana M, Matousovic K, Julian BA, et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 1997;52(2):509–516. DOI: 10.1038/ki.1997.361

[192] Tomana M., Matousovic K., Julian B.A. et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG // Kidney Int. 1997. Vol. 52, No. 2. P. 509–516. DOI: 10.1038/ki.1997.361

[193] Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119(6):1668–1677. DOI: 10.1172/JCI38468

[194] Suzuki H., Fan R., Zhang Z. et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity // J. Clin. Invest. 2009. Vol. 119, No. 6. P. 1668–1677. DOI: 10.1172/JCI38468

[195] Coppo R. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant. 2015;30(3):360–366. DOI: 10.1093/ndt/gfu343

[196] Coppo R. The intestine-renal connection in IgA nephropathy // Nephrol. Dial. Transplant. 2015. Vol. 30, No. 3. P. 360–366. DOI: 10.1093/ndt/gfu343

[197] Tanaka M, Seki G, Someya T, et al. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy. Clin Dev Immunol. 2011;2011:470803. DOI: 10.1155/2011/470803

[198] Tanaka M., Seki G., Someya T. et al. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy // Clin. Dev. Immunol. 2011. Vol. 2011. P. 470803. DOI: 10.1155/2011/470803

[199] Piccolo M, De Angelis M, Lauriero G, et al. Salivary microbiota associated with immunoglobulin A nephropathy. Microb Ecol. 2015;70(2):557–565. DOI: 10.1007/s00248-015-0592-9

[200] Piccolo M., De Angelis M., Lauriero G. et al. Salivary microbiota associated with immunoglobulin A nephropathy // Microb. Ecol. 2015. Vol. 70, No. 2. P. 557–565. DOI: 10.1007/s00248-015-0592-9

[201] Meng H, Ohtake H, Ishida A, et al. IgA production and tonsillar focal infection in IgA nephropathy. J Clin Exp Hematop. 2012;52(3):161–170. DOI: 10.3960/jslrt.52.161

[202] Meng H., Ohtake H., Ishida A. et al. IgA production and tonsillar focal infection in IgA nephropathy // J. Clin. Exp. Hematop. 2012. Vol. 52, No. 3. P. 161–170. DOI: 10.3960/jslrt.52.161

[203] Nakata J, Suzuki Y, Suzuki H, et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PloS One. 2014;9(2):e89707. DOI: 10.1371/journal.pone.0089707

[204] Nakata J., Suzuki Y., Suzuki H. et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy // PloS One. 2014. Vol. 9, No. 2. P. e89707. DOI: 10.1371/journal.pone.0089707

[205] Schmitt R, Carlsson F, Mörgelin M, et al. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura. Am J Pathol. 2010;176(2):608–618. DOI: 10.2353/ajpath.2010.090428

[206] Schmitt R., Carlsson F., Mörgelin M. et al. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura // Am. J. Pathol. 2010. Vol. 176, No. 2. P. 608–618. DOI: 10.2353/ajpath.2010.090428

[207] Schmitt R, Ståhl A, Olin A, et al. The combined role of galactose-deficient IgA1 and streptococcal IgA-Binding M protein in inducing IL-6 and C3 secretion from human mesangial cells: Implications for IgA nephropathy. J Immunol. 2014;193(1):317–326. DOI: 10.4049/jimmunol.1302249

[208] Schmitt R., Ståhl A., Olin A. et al. The combined role of galactose-deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy // J. Immunol. 2014. Vol. 193, No. 1. P. 317–326. DOI: 10.4049/jimmunol.1302249

[209] Burova LA, Pigarevsky PV, Snegova VA, et al. Nephritogenic activity of IgA-binding Streptococcus pyogenes. An experimental model of IgA glomerulonephritis. Medical Immunology. 2016;18(3):221–230. (In Russ.) DOI: 10.15789/1563-0625-2016-3-221-230

[210] Бурова Л.А., Пигаревский П.В., Снегова В.А. и др. Нефритогенность IgA-связывающих Streptococcus pyogenes. Моделирование IgA-гломерулонефрита // Медицинская иммунология. 2016. Т. 18, № 3. С. 221–230. DOI: 10.15789/1563-0625-2016-3-221-230

[211] Hashimoto A, Suzuki Y, Suzuki H, et al. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes. Am J Pathol. 2012;181(4):1338–1347. DOI: 10.1016/j.ajpath.2012.06.038

[212] Hashimoto A., Suzuki Y., Suzuki H. et al. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes // Am. J. Pathol. 2012. Vol. 181, No. 4. P. 1338–1347. DOI: 10.1016/j.ajpath.2012.06.038

[213] Kovalenko P, Fujinaka H, Yoshida Y, et al. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by antiglomerular basement membrane antibody administration in WKY rats. Int Immunol. 2004;16(5):625–634. DOI: 10.1093/intimm/dxh058

[214] Kovalenko P., Fujinaka H., Yoshida Y. et al. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by antiglomerular basement membrane antibody administration in WKY rats // Int. Immunol. 2004. Vol. 16, No. 5. P. 625–634. DOI: 10.1093/intimm/dxh058

[215] Tian J, Wang Y, Zhou X, et al. Rapamycin slows IgA nephropathy progression in the rat. Am J Nephrol. 2014;39(3):218–229. DOI: 10.1159/000358844

[216] Tian J., Wang Y., Zhou X. et al. Rapamycin slows IgA nephropathy progression in the rat // Am. J. Nephrol. 2014. Vol. 39, No. 3. P. 218–229. DOI: 10.1159/000358844

[217] Jessen RH, Emancipator SN, Jacobs GH, Nedrud JG. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status. Lab Invest. 1992;67(3):379–386.

[218] Jessen R.H., Emancipator S.N., Jacobs G.H., Nedrud J.G. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status // Lab. Invest. 1992. Vol. 67, No. 3. P. 379–386.

[219] Okazaki K, Suzuki Y, Otsuji M, et al. Development of a model of early-onset IgA nephropathy. J Am Soc Nephrol. 2012;23(8):1364–1374. DOI: 10.1681/ASN.2011121160

[220] Okazaki K., Suzuki Y., Otsuji M. et al. Development of a model of early-onset IgA nephropathy // J. Am. Soc. Nephrol. 2012. Vol. 23, No. 8. P. 1364–1374. DOI: 10.1681/ASN.2011121160

[221] Suzuki H, Suzuki Y, Novak J, Tomino Y. Development of animal models of human IgA nephropathy. Drug Discov Today Dis Models. 2014;11:5–11. DOI: 10.1016/j.ddmod.2014.07.002

[222] Suzuki H., Suzuki Y., Novak J., Tomino Y. Development of animal models of human IgA nephropathy // Drug. Discov. Today Dis. Models. 2014. No. 11. P. 5–11. DOI: 10.1016/j.ddmod.2014.07.002

[223] Berthelot L, Monteiro RC. Formation of IgA deposits in Berger’s disease: what we learned from animal models. Biol Aujourdhui. 2013;207(4):241–247. (In French) DOI: 10.1051/jbio/2013022

[224] Berthelot L., Monteiro R.C. Formation of IgA deposits in Berger’s disease: what we learned from animal models // Biol. Aujourdhui. 2013. Vol. 207, No. 4. P. 241–247. (In French) DOI: 10.1051/jbio/2013022

[225] Berthelot L, Papista C, Maciel TT, et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med. 2012;209(4):793–806. DOI: 10.1084/jem.20112005

[226] Berthelot L., Papista C., Maciel T.T. et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors // J. Exp. Med. 2012. Vol. 209, No. 4. P. 793–806. DOI: 10.1084/jem.20112005

[227] Barratt J, Smith AC, Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton). 2007;12(3):275–284. DOI: 10.1111/j.1440-1797.2007.00797.x

[228] Barratt J., Smith A.C., Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy // Nephrology (Carlton). 2007. Vol. 12, No. 3. P. 275–284. DOI: 10.1111/j.1440-1797.2007.00797.x

[229] Liu H, Peng Y, Liu F, et al. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy. Inflamm Res. 2011;60(9):869–878. DOI: 10.1007/s00011-011-0347-0

[230] Liu H., Peng Y., Liu F. et al. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy // Inflamm. Res. 2011. Vol. 60, No. 9. P. 869–878. DOI: 10.1007/s00011-011-0347-0

RIGHTS & PERMISSIONS

Eco-Vector